Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid
A technology of fatty acid and fatty acid metabolism, applied in medical preparations containing active ingredients, drug combinations, anhydride/acid/halide active ingredients, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0134] Example 1: Supplementation in Cell Lines
[0135] Addition of n-heptanoic acid to a cultured cell line (fibroblasts) from a lethal translocase-deficient patient showed a successful oxidation reaction.
[0136] Amnion cells from a sibling who died of severe translocase deficiency at 4 days of age were obtained to test their survival conditions in fatty acid metabolism. These experiments revealed that the fetus was also severely deficient in translocase.
[0137] Fibroblasts from dead siblings and amniocytes from the fetus were evaluated for n-heptanoic acid (C 7 ) fatty acid metabolism (Yang et al., 1998, "Identification of four novel mutants in patients deficient in carnitine palmitoyltransferase II (CPT II), Mol Genet Metab 64: 229-236). The mass spectrometry results are given as follows: palmitate in Figure 3A and enanthin triglyceride in Figure 3B, where fibroblasts were obtained from dead siblings, and palmitate in Figure 4A, in Figure 3B Figure 4B is enanthin tr...
Embodiment 2
[0144] Example 2: In Vivo Utilization of Enanthate Triglyceride Supplementation in Patients with Severe Translocase Deficiency
[0145] Infants with severe neonatal translocase deficiency identified in Example 1 were successfully treated with the low-fat formulation supplemented with enanthin triglycerides. Furthermore, the relationship between clinical response to enanthate triglyceride treatment and in vitro mass spectrometry analysis of infant amnion cells was mutually supported.
[0146] At 38 weeks' gestation, infants whose amniocytes tested positive for severe translocase deficiency as described in Example 1 were delivered. Cord blood total and free carnitine levels, as well as individual acylcarnitine levels, were analyzed by tandem mass spectrometry (Yang et al., 1998, "Identification of four novel mutants in carnitine palmitoyltransferase II (CPTII) deficient patients" , Mol Genet Metab 64:229-236). The levels of these substances in the mother's blood are also teste...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com